Evans syndrome in a patient with COVID‐19

Evans syndrome (ES) is a rare condition characterized by the combination of autoimmune hemolytic anemia and immune thrombocytopenia (ITP). While the precise pathophysiology is not entirely understood, it is believed that dysregulation of the immune system is a primary contributor to the condition. E...

Full description

Saved in:

Bibliographic Details
Published in:	British journal of haematology 2020-07, Vol.190 (2), p.e59-e61
Main Authors:	Li, Monica, Nguyen, Charles B., Yeung, Zachary, Sanchez, Katherine, Rosen, Daniel, Bushan, Sita
Format:	Article
Language:	eng
Subjects:	anaemia clinical haematology Correspondence COVID-19 Hematology immune thrombocytopenia
Online Access:	Request full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Evans syndrome (ES) is a rare condition characterized by the combination of autoimmune hemolytic anemia and immune thrombocytopenia (ITP). While the precise pathophysiology is not entirely understood, it is believed that dysregulation of the immune system is a primary contributor to the condition. ES has been observed in viral infections including hepatitis C, cytomegalovirus, varicella-zoster, and Epstein-Barr viruses (1-4). Initial cases of coronavirus disease 2019 (COVID-19) were first described in early December 2019 and has now spread to a global pandemic. While knowledge about COVID-19 continues to evolve, clinicians have reported hematologic complications associated with the virus.
ISSN:	0007-1048 1365-2141